XTAMPZAER (Collegium Pharmaceutical, Inc.)
Welcome to the PulseAid listing for the XTAMPZA drug offered from Collegium Pharmaceutical, Inc.. This Full Opioid Agonists [MoA],Opioid Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Collegium Pharmaceutical, Inc. |
NON-PROPRIETARY NAME: | OXYCODONE |
SUBSTANCE NAME: | OXYCODONE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE, EXTENDED RELEASE |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2016-05-10 |
END MARKETING DATE: | 0000-00-00 |
XTAMPZA ER HUMAN PRESCRIPTION DRUG Details:
Item Description | XTAMPZA ER from Collegium Pharmaceutical, Inc. |
LABELER NAME: | Collegium Pharmaceutical, Inc. |
DEA SCHEDULE: | CII
|
ACTIVE STRENGTH: | 9(mg/1) |
START MARKETING DATE: | 2016-05-10 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 24510-110_29be3690-7b9a-482d-b28c-f93b25539b84 |
PRODUCT NDC: | 24510-110 |
APPLICATION NUMBER: | NDA208090 |
Other OXYCODONE Pharmaceutical Manufacturers / Labelers: